Gleiss Lutz has advised the listed Chinese Triumph Science and Technology Group Co., Ltd. ("Triumph"), a manufacturer of specialty glass and display technologies, on the sale of shares in SINGULUS TECHNOLOGIES AG ("Singulus") to a European investor.
Triumph is listed on the Shanghai Stock Exchange and is one of the world’s leading suppliers of ultra-thin glass for displays and touchscreens. Singulus, headquartered in Kahl am Main, is an internationally active machinery and equipment manufacturer specializing in thin-film technology and surface treatment, developing production systems for the solar, semiconductor and medical technology industries, among others.
A corresponding share purchase agreement for the sale of approximately 1.5 million Singulus shares (approximately 16.75%) held by Triumph has been signed by both parties and remains subject to approval by the relevant government authorities in China.
For many years, Gleiss Lutz’s China Practice has been advising Chinese companies on investments and transactions in Germany and Europe and German clients with their business matters in China.
The following Gleiss Lutz team advised Triumph: Dr. Michael Burian (partner, Frankfurt), Dr. Yixiao Li (partner, both lead), Dr. Markus Martin (counsel), Alexandra Brücher, Dr. Ronald Ng (all M&A, all Stuttgart), Dr. Katja Lehr (counsel, Banking & Finance, Frankfurt).
Forward
